DESIPRAMINE HYDROCHLORIDE (Page 4 of 4)

MEDICATION GUIDE

Desipramine Hydrochloride Tablets, USP

(des-IP-ra-meen HYE-droe-KLOR-ide)

Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions

Read the Medication Guide that comes with your, or your family member’s, antidepressant medicine. This Medication Guide is only about the risk of suicidal thoughts and actions with antidepressant medicines. Talk to your, or your family member’s, healthcare provider about:

  • all risks and benefits of treatment with antidepressant medicines
  • all treatment choices for depression or other serious mental illness

What is the most important information I should know about antidepressant medicines, depression and other serious mental illnesses, and suicidal thoughts or actions?

  1. Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults within the first few months of treatment.
  2. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Some people may have a particularly high risk of having suicidal thoughts or actions. These include people who have (or have a family history of) bipolar illness (also called manic-depressive illness) or suicidal thoughts or actions.
  3. How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member?
    • Pay close attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. This is very important when an antidepressant medicine is started or when the dose is changed.
    • Call the healthcare provider right away to report new or sudden changes in mood, behavior, thoughts, or feelings.
    • Keep all follow-up visits with the healthcare provider as scheduled. Call the healthcare provider between visits as needed, especially if you have concerns about symptoms.

Who should not take desipramine hydrochloride tablets, USP?

  • You should not take desipramine hydrochloride tablets, USP if you take a monoamine oxidase inhibitor (MAOI). Ask your healthcare provider or pharmacist if you are not sure if you take an MAOI, including the antibiotic linezolid.
  • Do not take an MAOI within 2 weeks of stopping desipramine hydrochloride tablets, USP unless directed to do so by your physician.
  • Do not start desipramine hydrochloride tablets, USP if you stopped taking an MAOI in the last 2 weeks unless directed to do so by your physician.

Call a healthcare provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or worry you:

  • thoughts about suicide or dying
  • attempts to commit suicide
  • new or worse depression
  • new or worse anxiety
  • feeling very agitated or restless
  • panic attacks
  • trouble sleeping (insomnia)
  • new or worse irritability
  • acting aggressive, being angry, or violent
  • acting on dangerous impulses
  • an extreme increase in activity and talking (mania)
  • other unusual changes in behavior or mood

Visual Problems

  • eye pain
  • changes in vision
  • swelling or redness in or around the eye

Only some people are at risk for these problems. You may want to undergo an eye examination to see if you are at risk and receive preventative treatment if you are.

What else do I need to know about antidepressant medicines?

  • Never stop an antidepressant medicine without first talking to a healthcare provider. Stopping an antidepressant medicine suddenly can cause other symptoms.
  • Antidepressants are medicines used to treat depression and other illnesses. It is important to discuss all the risks of treating depression and also the risks of not treating it. Patients and their families or other caregivers should discuss all treatment choices with the healthcare provider, not just the use of antidepressants.
  • Antidepressant medicines have other side effects. Talk to the healthcare provider about the side effects of the medicine prescribed for you or your family member.
  • Antidepressant medicines can interact with other medicines. Know all of the medicines that you or your family member takes. Keep a list of all medicines to show the healthcare provider. Do not start new medicines without first checking with your healthcare provider.
  • Not all antidepressant medicines prescribed for children are FDA approved for use in children. Talk to your child’s healthcare provider for more information.
  • Tell your healthcare provider if you are pregnant or plan to become pregnant during treatment with desipramine hydrochloride tablets, USP.
    • If you become pregnant during treatment with desipramine hydrochloride tablets USP, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants. You can register by calling 1-844-405-6185 or visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1800-FDA-1088.

You may also report side effects to Avet Pharmaceuticals Inc. at 1-866-901-DRUG (3784)

This Medication Guide has been approved by the U.S. Food and Drug Administration for all antidepressants.

Dispense with Medication Guide available at: www.avetpharma.com/product

Manufactured by:
USV Private Limited
Daman — 396210, India

Manufactured for:
Avet Pharmaceuticals Inc.
East Brunswick, NJ 088161.866.901.DRUG (3784)

logo
(click image for full-size original)

Revised: 06/2023

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 23155-578-01

Desipramine Hydrochloride Tablets, USP
10 mg
PHARMACIST: Dispense the enclosed Medication Guide to each patient.
100 Tablets
Rx onlyAvet Pharma Ltd.

10 mg
(click image for full-size original)

NDC 23155-579-01

Desipramine Hydrochloride Tablets, USP
25 mg
PHARMACIST: Dispense the enclosed Medication Guide to each patient.
100 Tablets
Rx onlyAvet Pharma Ltd.

25 mg
(click image for full-size original)

NDC 23155-580-01

Desipramine Hydrochloride Tablets, USP
50 mg
PHARMACIST: Dispense the enclosed Medication Guide to each patient.
100 Tablets
Rx onlyAvet Pharma Ltd.

50 mg
(click image for full-size original)

NDC 23155-581-01

Desipramine Hydrochloride Tablets, USP
75 mg
PHARMACIST: Dispense the enclosed Medication Guide to each patient.
100 Tablets
Rx onlyAvet Pharma Ltd.

75 mg
(click image for full-size original)

NDC 23155-582-01

Desipramine Hydrochloride Tablets, USP
100 mg
PHARMACIST: Dispense the enclosed Medication Guide to each patient.
100 Tablets
Rx onlyAvet Pharma Ltd.

100 mg
(click image for full-size original)

NDC 23155-583-25

Desipramine Hydrochloride Tablets, USP
150 mg
PHARMACIST: Dispense the enclosed Medication Guide to each patient.
50 tablets
Rx onlyAvet Pharma Ltd.

150 mg
(click image for full-size original)
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-578
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE) DESIPRAMINE HYDROCHLORIDE 10 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
HYPROMELLOSE 2910 (6 MPA.S)
TALC
POLYETHYLENE GLYCOL 8000
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (White to Off White) Score no score
Shape SQUARE (Rounded Square) Size 4mm
Flavor Imprint Code N6
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-578-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA207433 11/01/2016
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-579
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE) DESIPRAMINE HYDROCHLORIDE 25 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
HYPROMELLOSE 2910 (6 MPA.S)
TALC
POLYETHYLENE GLYCOL 8000
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (White to Off White) Score no score
Shape ROUND (Round Biconvex) Size 6mm
Flavor Imprint Code I86
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-579-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA207433 11/01/2016
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-580
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE) DESIPRAMINE HYDROCHLORIDE 50 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
HYPROMELLOSE 2910 (6 MPA.S)
TALC
POLYETHYLENE GLYCOL 8000
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (White to Off White) Score no score
Shape ROUND (Round Biconvex) Size 8mm
Flavor Imprint Code I82
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-580-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA207433 11/01/2016
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-581
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE) DESIPRAMINE HYDROCHLORIDE 75 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
HYPROMELLOSE 2910 (6 MPA.S)
TALC
POLYETHYLENE GLYCOL 8000
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (White to Off White) Score no score
Shape ROUND (Round Biconvex) Size 9mm
Flavor Imprint Code I83
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-581-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA207433 11/01/2016
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-582
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE) DESIPRAMINE HYDROCHLORIDE 100 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
HYPROMELLOSE 2910 (6 MPA.S)
TALC
POLYETHYLENE GLYCOL 8000
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (White to Off White) Score no score
Shape ROUND (Round Biconvex) Size 10mm
Flavor Imprint Code I84
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-582-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA207433 11/01/2016
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-583
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE) DESIPRAMINE HYDROCHLORIDE 150 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
HYPROMELLOSE 2910 (6 MPA.S)
TALC
POLYETHYLENE GLYCOL 8000
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (White to Off White) Score no score
Shape ROUND (Round Biconvex) Size 11mm
Flavor Imprint Code I85
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-583-25 50 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA207433 11/01/2016
Labeler — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (780779901)
Establishment
Name Address ID/FEI Operations
USV Private Limited 650434348 analysis (23155-578), manufacture (23155-578), label (23155-578), pack (23155-578), analysis (23155-579), manufacture (23155-579), label (23155-579), pack (23155-579), analysis (23155-580), manufacture (23155-580), label (23155-580), pack (23155-580), analysis (23155-581), manufacture (23155-581), label (23155-581), pack (23155-581), analysis (23155-582), manufacture (23155-582), label (23155-582), pack (23155-582), analysis (23155-583), manufacture (23155-583), label (23155-583), pack (23155-583)

Revised: 08/2023 Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.